We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+29.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$264M
Cap. Flow
-$56.9M
Cap. Flow %
-3.61%
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24

Top Buys

Rank Stock Value
1
JOYY
JOYY Inc
JOYY
+$3.5M
2
WB icon
Weibo
WB
+$2.7M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.76M
4
HSAI
Hesai Group
HSAI
+$1.67M
5
GPCR icon
Structure Therapeutics
GPCR
+$1.64M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$23.4M
2
YUMC icon
Yum China
YUMC
+$14M
3
TSM icon
TSMC
TSM
+$8.84M
4
PDD icon
Pinduoduo
PDD
+$8.79M
5
AAPL icon
Apple
AAPL
+$4.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 50.26%
2 Technology 23.48%
3 Communication Services 8.85%
4 Real Estate 5.2%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCVX icon
151
Vaxcyte
PCVX
$8.92B
$532K 0.03%
8,476
+60
+0.7% +$3.12K
SRPT icon
152
Sarepta Therapeutics
SRPT
$2.24B
$532K 0.03%
5,519
+1,705
+45% +$164K
EXEL icon
153
Exelixis
EXEL
$13.4B
$524K 0.03%
21,832
+1,150
+6% +$25K
TGTX icon
154
TG Therapeutics
TGTX
$8.34B
$522K 0.03%
30,553
-13,457
-31% -$156K
NTRA icon
155
Natera
NTRA
$47.4B
$517K 0.03%
8,260
-177
-2% -$8.84K
IMVT icon
156
Immunovant
IMVT
$8.64B
$516K 0.03%
12,256
-2,989
-20% -$110K
ALKS icon
157
Alkermes
ALKS
$8.01B
$515K 0.03%
18,573
+2,723
+17% +$70.7K
CDW icon
158
CDW
CDW
$18.4B
$514K 0.03%
2,262
+1,044
+86% +$221K
PCAR icon
159
PACCAR
PCAR
$65.8B
$512K 0.03%
5,244
-505
-9% -$45.4K
GEHC icon
160
GE HealthCare
GEHC
$32.4B
$507K 0.03%
6,556
+294
+5% +$20.6K
NTLA icon
161
Intellia Therapeutics
NTLA
$1.8B
$505K 0.03%
16,551
+4,476
+37% +$129K
ANET icon
162
Arista Networks
ANET
$246B
$502K 0.03%
8,524
-584
-6% -$30.7K
CCL icon
163
Carnival Corporation Ltd
CCL
$34B
$501K 0.03%
+27,038
New +$393K
PTCT icon
164
PTC Therapeutics
PTCT
$5.86B
$501K 0.03%
18,188
+7,589
+72% +$174K
APH icon
165
Amphenol
APH
$195B
$501K 0.03%
10,100
-732
-7% -$32.3K
NUVL
166
DELISTED
Nuvalent
NUVL
$500K 0.03%
6,798
+1,883
+38% +$117K
CRWD icon
167
CrowdStrike
CRWD
$222B
$500K 0.03%
7,836
-696
-8% -$36.4K
MRTX
168
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$500K 0.03%
8,503
-4,320
-34% -$243K
IONS icon
169
Ionis Pharmaceuticals
IONS
$10.2B
$499K 0.03%
9,865
-1,231
-11% -$59K
BMRN icon
170
BioMarin Pharmaceuticals
BMRN
$12.4B
$498K 0.03%
5,168
+98
+2% +$8.67K
BEAM icon
171
Beam Therapeutics
BEAM
$3.03B
$495K 0.03%
18,174
+704
+4% +$17.5K
IMGN
172
DELISTED
Immunogen Inc
IMGN
$488K 0.03%
16,443
-12,682
-44% -$253K
ROST icon
173
Ross Stores
ROST
$73.5B
$470K 0.03%
3,394
-355
-9% -$44.2K
SNDX icon
174
Syndax Pharmaceuticals
SNDX
$1.76B
$466K 0.03%
21,580
+6,986
+48% +$107K
CPRT icon
175
Copart
CPRT
$30.6B
$465K 0.03%
9,494
-855
-8% -$40.4K
5 6
7
8 9

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q4 2023 Portfolio in Review

As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.

  • E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
  • E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
  • E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
  • E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
  • E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
  • E Fund Management opened 38 new positions and closed 24 in Q4 2023.
  • E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.

Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.